Back to RXRX
ProShare Advisors LLC RXRX Position History
Recursion Pharmaceuticals, Inc.
Quarters held
5
Latest value
$342K
Q3 2026
Peak value
$380K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $380K |
| Q4 2025 | $377K |
| Q1 2026 | $276K |
| Q2 2026 | $309K |
| Q3 2026 | $342K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $342K | 82.8K | — | — |
| Q2 2026 | $309K | 84.2K | — | — |
| Q1 2026 | $276K | 89.8K | — | — |
| Q4 2025 | $377K | 92.2K | — | — |
| Q3 2025 | $380K | 77.9K | — | — |